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S. W. WERNS, J. C. FANTONE, A. VENTURA, B. R. LUCCHESI. Myocardial Glutathione Depletion Impairs 
Recovery of Isolated Blood-Perfused Hearts After Global Ischaemia. Journal of Molecular and Cellular Cardiology 
(1992) 24, 1215-1220. This study was performed to determine whether depletion of myocardial glutathionr 
would impair recovery of left ventricular function of blood-perfused, isolated hearts after reversible ischaemic 
injury. Cats were treated with either vehicle or buthionine sulfoximine (BSO), an inhibitor of gamma- 
glutamylcysteine synthetase, the rate-limiting enzyme in the synthesis of glutathione. The feline isolated hearts 
were perfused with the blood of normal donor cats before and after 40 min ofglobal myocardial ischaemia. The 
myocardial concentration of glutathione of the BSO group, 178 f 38 ng/mg tissue, was significantly less than 
that of the control group, 292* 38 ng/mg tissue (PcO.05). The peak left ventricular developed pressure 
(LVDP) 1 h after reperlnsion, expressed as a fraction of the peak LVDP before ischaemia, was 0.87 f 0.10 for 
the control group and 0.64 f 0.08 for the BSO group (P= 0.05 us. control). The peak left ventricular dP/dt after 
reperfusion, expressed as a fraction of the peak dP/dt before ischaemia, was 1.08f0.14 for the control group 
and 0.78+0.09 for the BSO group (P=O.O5 us. control). The myocardial creatine kinase activity of the BSO 
group, 1046 f 46 U/g tissue, was not significantly different from that of the control group, 1038 f 17 U/g tissue 
fP=O.87). Thus, depletion of myocardial glutathione resulted in impaired post-ischaemic contractile function 
that cannot be attributed to a greater extent of irreversible cell injury. 
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Introduction 
Ylyocardial stunning refers to the delayed 
recovery of contractile function after either 
regional or global myocardial ischaemia 
which results in reversible myocardial injury 
[I]. Numerous studies have supported the 
hypothesis that the pathogenesis of myocar- 
dial stunning involves the formation of oxy- 
gen metabolites, such as superoxide anion, 
hydrogen perioxide and hydroxyl radical [I]. 
Reduced glutathione (GSH) and glutathione 
peroxidase constitute the major intracellular 
defenses against damage by hydrogen perox- 
ide and lipid hydroperoxides [Z, 31. This study 
was designed to evaluate the importance of 
myocardial glutathione by determining the 
effect of myocardial glutathione depletion on 
myocardial stunning after global myocardial 
ischaemia. Depletion of glutathione was 
achieved by treatment with buthionine sul- 
foximine (BSO) , an inhibitor of gamma- 
glutamylcysteine synthetase, the rate-limiting 
enzyme in the synthesis of glutathionr 141. 
Methods 
Preparation of blood-donor tut 
The blood-perfused, feline isolated heart pre- 
paration was developed by Vogel and Luc- 
chesi [.‘Fl and has been used to study the effects 
of a variety of pharmacological interventions, 
including /3-adrenergic blockade [S]> calcium 
channel blockade [q, and SOD and catalase 
[8], on myocardial injury due to global isch- 
aemia and reperfusion. Hearts from mongrel 
cats of either sex were isolated and perfused 
via the aorta with blood drawn from a blood- 
donor cat. Blood-donor cats (3-5 kg) were 
anesthetized with 0.7 ml/kg iv of a dial-urrth- 
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ane solution containing: allobarbital, 100 g/l; 
urethane, 400 g/l; monoethylurea, 400 g/l. 
The cats were anticoagulated with 300 U/kg 
iv sodium heparin. A femoral vein was isol- 
ated, cannulated and connected through a 
roller pump to a venous reservoir. The reser- 
voir level was adjusted to maintain the dia- 
stolic blood pressure of the blood-donor cat 
above 75 mmHg. One femoral artery was 
isolated, cannulated and connected to a 
second roller pump for withdrawal of arterial 
blood. The other femoral artery was cannul- 
ated to monitor systemic blood pressure. The 
trachea was cannulated for positive-pressure 
ventilation. Tidal volume was adjusted to 
maintain arterial pH, PO,, and Pco, within 
normal limits. 
Preparation of isolated heart 
Buthionine sulfoximine was obtained from 
Sigma Chemical, St. Louis, MI. After pre- 
paration of the donor cat as described above, 
the control or BSO-treated cats were anesthet- 
ized with 35 mg/kg iv sodium pentobarbital 
and anticoagulated with 300 U/kg iv sodium 
heparin. The heart was excised quickly and 
mounted on the perfusion apparatus. Arterial 
blood, drawn by the roller pump from the 
blood-donor cat, was maintained at 37°C by a 
heat exchanger and monitored continuously 
with a thermistor probe. The perfusion pres- 
sure was recorded with a pressure transducer 
connected to a side arm of the aortic cannula, 
and was maintained at 75 mmHg by 
manually varying the flow rate of the perfu- 
sion pump. The isolated hearts were sus- 
pended in a water-jacketed vessel maintained 
at 37°C. During ischaemic arrest the hearts 
were immersed in 0.9% sodium chloride solu- 
tion. Otherwise the hearts were kept moist by 
periodically applying 0.9% sodium chloride 
to the surface. 
The vena cava and pulmonary veins were 
ligated and the pulmonary artery was cannul- 
ated to collect the coronary venous effluent, 
which was returned to the jugular vein of the 
blood-donor cat via the venous reservoir and 
roller pump. A left ventricular drainage can- 
nula was secured at the apex of the heart with 
purse string sutures. Blood collected through 
the drainage cannula (< 1 ml/min) was 
returned to the venous reservoir. The hearts 
were paced electrically from the right atria1 
appendage at a rate of 150 beats/min. An 
electrocardiogram was recorded from the isol- 
ated heart with one electrode attached to the 
aortic cannula and another to the apex of the 
heart. 
Left ventricular volume was controlled 
with a water-filled latex balloon placed in the 
ventricle through the left atria1 appendage. 
The balloon was connected by a short length 
of stiff polyethylene tubing to a syringe and a 
pressure transducer. Left ventricular pressure 
and its electronically derived first derivative 
(dP/dt) were recorded through this system. 
Ventricular function curves were inscribed by 
increasing the volume of the balloon by 0.2 ml 
increments so that ventricular diastolic pres- 
sure varied between 0 and 35 mmHg. 
After stabilization for 60 min, the left vent- 
ricular pressure and dP/dt were recorded for 
left ventricular end-diastolic pressures varying 
from 0 to 35 mmHg by adjusting the balloon 
volume. The balloon volume was adjusted to 
the value that produced a left ventricular 
diastolic pressure of 15 mmHg. The hearts 
were subjected to zero-flow ischaemia for 
40 min, followed by reperfusion. Fifty per 
cent of the hearts from each group developed 
ventricular fibrillation after reperfusion and 
were defibrillated with injections of 100~1 of 
saturated KC1 solution into the perfusion can- 
nula. The perfusate was not allowed to recir- 
culate. After reperfusion for 60 min the hemo- 
dynamic measurements were repeated. 
Tissue creatine kinase and glutathione 
Samples of blood were obtained from the 
pulmonary artery cannula 10 min after reper- 
fusion to measure oxidized glutathione as 
described below. After reperfusion for 60 min 
and recording of the post-ischaemic left vent- 
ricular function curves, the hearts were per- 
fused with 100 ml of Kreb’s buffer to wash out 
the blood in the vascular space. The hearts 
were then freeze-clamped with tongs pre- 
cooled in liquid nitrogen. 
Creatine kinase 
Previous studies have shown that the myocar- 
dial CK activity of isolated, blood-perfused 
cat hearts was unchanged after 40 min of 
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ischaemia, suggesting reversible cell injury 
[:!I. The myocardial CK activities were deter- 
mined using a commercial spectrophotometric 
assay (Sigma Chemical, St. Louis, MI). Phos- 
phocreatine formed in the CK-catalyzed reac- 
tion between ATP and creatine is hydrolyzed 
to yield inorganic phosphorus, which is quant- 
itated by the Fiske and SubbaRow method. 
Thus, the myocardium was homogenized in a 
phosphate-free buffer of 250 mM sucrose, 
1 mM EDTA, 0.1 mM mercaptoethanol [9]. 
‘l’he CK activities of tissue samples was extra- 
polated from a standard curve of phosphate 
and CK standards. 
Glutathione 
‘l‘he myocardial concentration of total glu- 
tathione was measured as described by Grif- 
fith and Meister [IO]. The assay for GSH is an 
enzymatic recycling assay in which GSH is 
sequentially oxidized by 5,5-dithiobis(2-nitro- 
benzoic acid) (DTNB) and reduced by glu- 
tathione reductase and NADPH [II]. The 
rate of 5-thio-2-nitrobenzoic acid formation is 
monitored at 412 nm, and is proportional to 
the sum of GSH and 2X GSSG. The gluta- 
thionc concentration of the tissue sample was 
extrapolated from a standard curve. 
‘I’hr concentration of oxidized glutathione 
in pulmonary artery plasma was measured as 
described by Anderson [II]. Fifty microliters 
of .500 mM EDTA was added to 5 ml of blood. 
:\liquots of 400~1 were centrifuged at 
10 000 g for 90 seconds. One hundred ~1 of 
IO’% hulfosalicyclic acid was added to 200 ~1 
aliquots ofplasma and centrifuged at 10 000 g 
for 5 min. The supernatants were stored over- 
night at 4°C. On the following day 4~1 of 2- 
vinylpyridine were added to 200 ~1 aliquots of 
supernatant. The samples were mixed with 
tip1 of rriethanolamine and incubated for 
60 min at room temperature. The concentra- 
tion of oxidized glutathione was extrapolated 
from a standard curve. 
Data analysis 
.\ll data are expressed as meansf~.~.~. Dif- 
ftirences were considered significant for 
/‘<0.05. An unpaired t test was used to com- 
pare the control and BSO groups. 
Results 
The first objective was to identify a schrdule 
of treatment with buthionine sulfoximinc 
(BSO) that significantly reduces the concen- 
tration of glutathione in the cat heart. The 
myocardial concentration of glutathione was 
998 + 79 ng/mg tissue (n= 2) in non-ischarmic 
cat hearts, a value similar to that reported lin 
the mouse heart [/0]. Four hours after the 
injection of BSO 1.6 g/kg ip. thr myocardial 
concentration of gtutathione was 790 ng/mg 
(n = 2). The concentration of ‘glutathionr w;ts 
6 17 ng/mg j II = 1) 18 11 after BSO 1.6 g/kg ill. 
After treatment with BSO 1.6 g/kg ip li)r 2 
days, the myocardial concentration of gtu- 
tathione was 272 ng/mg (n = 2). ‘l‘hrrcfbrc~, 
the latter schedule of administration was 
selected for subsequent experiments. 
Experiments were performed to examine 
the correlation between thr post-ischaemic 
recovery of left ventricular function and the 
myorardial concentration ofglutathionr. Cats 
were assigned randomly to treatment with 
either vehicle in = 6) or BSO in = 6) 1.6 g/kg ip 
42 and 18 h before the experiments. ‘I’hc peak 
left ventricular developed pressure L\‘l>1’1 
for the control group was I42 f  4 before isch- 
aemia and 12 1 f  12 after rrpcrfusion 
(P=O. 11; ser Fig. I ,I. The peak L\‘DP for the 
BSO group was 165 f  14 befhre isctiactmia and 
106 f  16 aftrr reprrfusion 1 P= 0.00.3 I, ‘I‘he 
peak L\‘DP after rrperfusion, cxprt~sst~cl as ;t 
fraction of the peak LVDP brfi,re isc,llaemia, 
was 0.87 f  0.10 for the control ,group and 
0.64f0.08 lbr the BSO group (P=O.O5 ;\. 
control). Similarly, thr prak left ventricular 
dP/dt after rcpcrfusion, expressrd ;W a liar- 
tion of the peak dP/df before ischacmia. \V~X 
1.08fO.14 fhr the control group and 
0.783~0.09 for thr BSO group iP=O.O5 i’). 
control; see Figure 1 I. 
After reperfusiori tbr IO min, rtie (‘onct’n- 
tration of oxidized glutathione in the pulmon- 
ary artery plasma was 6.3f0.2p~ fi,r the 
COntrOlS (n = 3 ;I compared ((1 ?1.3 f. 0.1 ,UM Ii)1 
the BSO group jn= 3; P<O.Ol D.\. controls,. 
The myocardial concentration of glutathionr 
was 292A 38 ng/m~g tissue for the c.ontrol 
group (n= 61, compared to 998f 79 rlg/tng 
for the non-ischaemic hearts (n = 2 I, Thus, 
ischaemia and rrprrfusion rrsultrd in ;L yub- 
stantial decline in thr’ myoc;jrdi;tl c.otlc‘t~ntr;l- 
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FIGURE 1. Left ventricular developed pressure and 
dP/dl before ischaemia and I h after reperfusion of the 
control group (n = 6) and BSO group (n = 6). 0 = Pre- 
ischaemia, H = post-reperfusion. 
tion of glutathione. The myocardial concen- 
tration of glutathione of the BSO group, 
178 f  38 ng/mg (a= 5)) was significantly less 
than that of the control group (PcO.05 us. 
control). There was a significant correlation 
between the myocardial concentration of glu- 
tathione and the peak LVDP after reperfu- 
sion expressed as a percentage of the peak 
LVDP before ischaemia (R = 0.64, P= 0.03). 
The myocardial creatine kinase activity 
(CK) of the BSO group, 1046 f  46 U/g tissue 
(n=5), was not significantly different from 
that of the control group, 1038 f  17 U/g tissue 
(n= 6; P= 0.87). Therefore, the depletion of 
glutathione appears to have caused an impair- 
ment of post-ischaemic contractile function 
that cannot be attributed to a greater extent 
of irreversible cell injury. 
Discussion 
The results demonstrate that ( 1) there is a 
significant reduction of the total glutathione 
concentration of cat hearts subjected to global 
ischaemia for 40 min followed by reperfusion 
for 60 min, (2) the myocardial concentration 
of glutathione is significantly reduced in cats 
treated with BSO and (3) inhibition of glu- 
tathione synthesis by treatment with BSO 
results in significantly less recovery of left 
ventricular developed pressure and dP/dt 
after global ischaemia and reperfusion. The 
results support the hypothesis that myocardial 
glutathione protects the heart against injury 
caused by ischaemia and reperfusion. 
Although myocardial glutathione depletion 
has been studied previously, a unique aspect 
of this study is the glutathione-depleted hearts 
were perfused with blood from a normal 
donor animal. Previous studies have examined 
either isolated crystalloid-perfused hearts 
[12], or the in-situ hearts of animals subjected 
to systemic depletion of glutathione 1131. Nor- 
mal erythrocytes contain catalase, glutathione 
peroxidase, and glutathione, and may serve as 
a major defense against the effects of hydro- 
gen peroxide [14-14. Toth et al. [14] reported 
that addition of human erythrocytes de- 
creased damage to cultured endothelial cells 
and isolated rat lungs which were exposed to 
hydrogen peroxide. Winterbourn et al. [15] 
demonstrated that human erythrocytes scav- 
enge extracellular hydrogen peroxide, inhibit- 
ing the formation of hypochlorous acid and 
hydroxyl radicals. Several studies have con- 
cluded that the protection from hydrogen 
peroxide by erythrocytes is mediated primar- 
ily by catalase [15, 171. Other investigators, 
however, have provided evidence that both 
erythrocyte catalase and glutathione can de- 
crease reperfusion injury [16]. Brown et al. 
[16] added human erythrocytes to the perfus- 
ate during reperfusion of isolated rat hearts 
after global ischaemia. Intact erythrocytes 
decreased the myocardial concentration of 
hydrogen peroxide and improved the recovery 
of ventricular function. The beneficial effect 
of the erythrocytes was reduced by treatment 
of the erythrocytes with either aminotriazole, 
which inactivates catalase, or N-ethyolmalei- 
mide, which both alkylates GSH and inhibits 
regeneration of GSH by GSH reductasr [18]. 
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The current study is the first to demonstrate 
the importance of myocardial glutathione in 
the presence of intact erythrocytes. 
Blaustein et al. [12] treated rats with 
diethylmaleate (DEM), which reduced the 
cardiac glutathione concentration to 35% of 
control hearts. The rat hearts were subjected 
to crystalloid perfusion and global ischaemia 
for 20 min. The glutathione-depleted hearts 
exhibited impaired recovery of systolic func- 
tion after reperfusion. DEM depletes glutath- 
ione via the formation of a thioether adduct, 
but it also inhibits protein synthesis, which 
might influence the results of the latter study 
[19]. BSO, however, does not inhibit protein 
synthesis, and reduces the concentration of 
glutathione by inhibiting gamma-glutamyl- 
cystrine synthetase, the rate-limiting enzyme 
in the synthesis of glutathione [IO, 19, 201. 
Only one previous study has employed BSO to 
inhibit myocardial glutathione synthesis [13]. 
The experimental preparation employed in 
the latter study, however, consisted of coron- 
ary artery occlusion in vivo, which resulted in 
myorardial infarction, and in addition to the 
heart, circulating erythrocytes, leukocytes and 
plasma were subjected to glutathione deple- 
tion. The experimental preparation utilized in 
the current study featured untreated erythro- 
qtes and leukocytes, and normal plasma, and 
the duration of ischaemia produces reversible 
myoc-ardial injury- rather than myocardial 
infarction. Previous work from this laboratory 
demonstrated a pattern of hemodynamic and 
biochemical changes consistent with reversible 
injury, i.e. myocardial stunning, after isol- 
ated, blood-perfused cat hearts were subjected 
to 40 min of ischaemia: impaired recovery of 
systolic function without the accumulation of 
calcium and loss of creatine kinase exhibited 
by infarcted tissue [4]. 
Additional studies have attempted to deter- 
mine whether an increased cellular concentra- 
tion of GSH would ameliorate post-ischaemic 
myocardial injury. Enrichment of the cardiac 
perfusate with GSH was reported to improve 
the recovery of left ventricular function of 
isolated rat hearts subjected to global isch- 
aemia and reperfusion [12, 211. The improve- 
ment in function, however, is probably not 
due to an increased intracellular pool of GSH. 
Glutathione itself is not effectively trans- 
ported into cells 1221, suggesting that the GSH 
in the cardiac perfusate may ha1.e exerted 
unrecognized effects. Employing a model of 
hypoxic injury to renal tubules, Weinberg rt 
al. [23J concluded that the cytoproterti\.e 
effect of exogenous GSH may be due to a 
protective effect of the glycine derived from 
GSH. The exogenous GSH added to isolated 
renal proximal tubules was degraded rapidl) 
to its component amino acids, glutamate, cyh- 
teine and glycine. Treatment with cysteine, 
but not glycine, increased the intracrllular 
concentration of GSH, but only glycine at- 
tenuated hypoxic in,jury to the renal tul)ul~~s. 
N-acetylcysteine has been shown to increase 
intracellular concentrations of‘ GSH by 
increasing the availability of cystcine [22]. 
Administration of N-acetylcysteine to dogs 
did not limit the extent of myocardial necrosis 
after coronary artery occlusion, although the 
post-ischaemic recovery of left \.c‘ntricular 
function was improved [24]. Compared to 
control hearts, isolated rabbit hearts treated 
continuously with N-acetylcysteinc before, 
during and after global ischaemia eshibited 
less efflux of creatine kinase and brtter left 
ventricular function after reperfusion [2.5]. 
The interpretation of the latter study is con- 
founded by the fact that pretreatmenc with 
N-acetylcysteine exerted only a modest effect 
on the post-ischaemic myocardial conccntra- 
tion of GSH 18.3 nmol/mg protein l’.\ 
6.5 nmol/mg protein in controls), and the 
addition of N-acetylcysteine to the perfusate 
throughout ischaemia and reperfusion would 
have exerted an antioxidant action. 
Ferrari r/ al. [21i] measured the release of 
GSH and oxidized glutathione from human 
hearts subjected to global myocardial isch- 
aemia during coronary artrry bypass grafting, 
and found indirect evidence of “oxidative 
stress” during reperfusion. Thus, both clinical 
and experimental studies suggest that myoc~ar- 
dial glutathione stores may he an important 
component of’ the heart’s suscrptibilit) to 
reperfusion in.jury. 
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